1. 4′-Demethylepipodophyllotoxin thenylidene glucoside (VM-26), a podophyllum compound with a new mechanism of action;Stahelin;Europ. J. Cancer,1970
2. Treatment schedule dependency of experimentally active antileukemic (L1210) drugs;Venditti;Cancer Chemother. Rep.,1971
3. Activity of a new glycosidic lignan derivative (VP16-213) related to podophyllotoxin in experimental tumors;Stahelin;Europ. J. Cancer,1973
4. Delayed toxicity of 4′-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-β-d-glucopyranoside) (NSC-122819; VM-16) in mice;Avery;Cancer Chemother. Rep.,1973
5. Phase I trial of the podophyllotoxin derivative VM-26;Trempe,1970